LPL Financial »

Relmada Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $58k 13k 4.65
2023-09-30 $39k 13k 3.00

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Us Treas Bd Etf (GOVT)
Ishares Tr Msci Usa Qlt Fct (QUAL)
NVIDIA Corporation (NVDA)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Amazon (AMZN)

View all positions for LPL Financial

Top funds holding Relmada Therapeutics

Vanguard Group
Acadian Asset Management
Parsons Capital Management
Opaleye Management
Palo Alto Investors
Franklin Resources
BlackRock
Millennium Management
Two Sigma Advisers
Geode Capital Management
Two Sigma Investments
Deutsche Bank Aktiengesellschaft
Bank of America Corporation
Marshall Wace
Bridgeway Capital Management

View all funds holding Relmada Therapeutics